nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Nateglinide—Enalapril—coronary artery disease	0.0774	0.129	CrCrCtD
Dextroamphetamine—Nateglinide—Trandolapril—coronary artery disease	0.0774	0.129	CrCrCtD
Dextroamphetamine—Aspartame—Trandolapril—coronary artery disease	0.0735	0.122	CrCrCtD
Dextroamphetamine—Aspartame—Enalapril—coronary artery disease	0.0735	0.122	CrCrCtD
Dextroamphetamine—Lisdexamfetamine—Lisinopril—coronary artery disease	0.0679	0.113	CrCrCtD
Dextroamphetamine—Nateglinide—Lisinopril—coronary artery disease	0.0606	0.101	CrCrCtD
Dextroamphetamine—Nateglinide—Ramipril—coronary artery disease	0.0587	0.0974	CrCrCtD
Dextroamphetamine—Aspartame—Lisinopril—coronary artery disease	0.0575	0.0955	CrCrCtD
Dextroamphetamine—Aspartame—Ramipril—coronary artery disease	0.0557	0.0925	CrCrCtD
Dextroamphetamine—CYP2D6—Niacin—coronary artery disease	0.017	0.173	CbGbCtD
Dextroamphetamine—CYP2D6—Timolol—coronary artery disease	0.0158	0.161	CbGbCtD
Dextroamphetamine—CYP2D6—Captopril—coronary artery disease	0.0139	0.141	CbGbCtD
Dextroamphetamine—CYP2D6—Simvastatin—coronary artery disease	0.0134	0.136	CbGbCtD
Dextroamphetamine—CYP2D6—Pravastatin—coronary artery disease	0.0132	0.134	CbGbCtD
Dextroamphetamine—CYP2D6—Lovastatin—coronary artery disease	0.0132	0.134	CbGbCtD
Dextroamphetamine—CYP2D6—Atorvastatin—coronary artery disease	0.012	0.122	CbGbCtD
Dextroamphetamine—Phenformin—KCNJ8—coronary artery disease	0.000969	0.221	CrCbGaD
Dextroamphetamine—Tolazoline—HRH2—coronary artery disease	0.000688	0.157	CrCbGaD
Dextroamphetamine—Lacosamide—CA5B—coronary artery disease	0.000503	0.115	CrCbGaD
Dextroamphetamine—Benzyl alcohol—ALDH2—coronary artery disease	0.000383	0.0872	CrCbGaD
Dextroamphetamine—Amphetamine—SLC22A3—coronary artery disease	0.000221	0.0503	CrCbGaD
Dextroamphetamine—Methamphetamine—SLC22A3—coronary artery disease	0.000205	0.0466	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—ADRB1—coronary artery disease	0.000175	0.0399	CrCbGaD
Dextroamphetamine—Ephedrine—ADRB2—coronary artery disease	0.000164	0.0374	CrCbGaD
Dextroamphetamine—Pseudoephedrine—ADRB1—coronary artery disease	0.000148	0.0337	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—ADRB2—coronary artery disease	0.000147	0.0336	CrCbGaD
Dextroamphetamine—Pseudoephedrine—TNF—coronary artery disease	0.000141	0.032	CrCbGaD
Dextroamphetamine—Nateglinide—PPARG—coronary artery disease	0.000138	0.0314	CrCbGaD
Dextroamphetamine—Body temperature increased—Trandolapril—coronary artery disease	0.000136	0.000721	CcSEcCtD
Dextroamphetamine—Abdominal pain—Trandolapril—coronary artery disease	0.000136	0.000721	CcSEcCtD
Dextroamphetamine—Dizziness—Ezetimibe—coronary artery disease	0.000136	0.00072	CcSEcCtD
Dextroamphetamine—Palpitations—Timolol—coronary artery disease	0.000136	0.00072	CcSEcCtD
Dextroamphetamine—Body temperature increased—Enalapril—coronary artery disease	0.000135	0.000718	CcSEcCtD
Dextroamphetamine—Abdominal pain—Enalapril—coronary artery disease	0.000135	0.000718	CcSEcCtD
Dextroamphetamine—Insomnia—Losartan—coronary artery disease	0.000135	0.000717	CcSEcCtD
Dextroamphetamine—Rash—Fenofibrate—coronary artery disease	0.000135	0.000717	CcSEcCtD
Dextroamphetamine—Dermatitis—Fenofibrate—coronary artery disease	0.000135	0.000716	CcSEcCtD
Dextroamphetamine—Tranylcypromine—CYP2C19—coronary artery disease	0.000135	0.0307	CrCbGaD
Dextroamphetamine—Decreased appetite—Furosemide—coronary artery disease	0.000135	0.000714	CcSEcCtD
Dextroamphetamine—Headache—Fenofibrate—coronary artery disease	0.000134	0.000712	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Captopril—coronary artery disease	0.000134	0.000712	CcSEcCtD
Dextroamphetamine—Urticaria—Telmisartan—coronary artery disease	0.000134	0.000711	CcSEcCtD
Dextroamphetamine—Vomiting—Clopidogrel—coronary artery disease	0.000134	0.00071	CcSEcCtD
Dextroamphetamine—Diarrhoea—Simvastatin—coronary artery disease	0.000134	0.00071	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000134	0.00071	CcSEcCtD
Dextroamphetamine—Chest pain—Ramipril—coronary artery disease	0.000134	0.000709	CcSEcCtD
Dextroamphetamine—Fatigue—Furosemide—coronary artery disease	0.000134	0.000709	CcSEcCtD
Dextroamphetamine—Tremor—Lisinopril—coronary artery disease	0.000134	0.000708	CcSEcCtD
Dextroamphetamine—Body temperature increased—Telmisartan—coronary artery disease	0.000134	0.000708	CcSEcCtD
Dextroamphetamine—Abdominal pain—Telmisartan—coronary artery disease	0.000134	0.000708	CcSEcCtD
Dextroamphetamine—Dyspnoea—Losartan—coronary artery disease	0.000133	0.000707	CcSEcCtD
Dextroamphetamine—Anxiety—Ramipril—coronary artery disease	0.000133	0.000707	CcSEcCtD
Dextroamphetamine—Vomiting—Lovastatin—coronary artery disease	0.000133	0.000706	CcSEcCtD
Dextroamphetamine—Somnolence—Losartan—coronary artery disease	0.000133	0.000705	CcSEcCtD
Dextroamphetamine—Dizziness—Eplerenone—coronary artery disease	0.000133	0.000705	CcSEcCtD
Dextroamphetamine—Rash—Clopidogrel—coronary artery disease	0.000133	0.000705	CcSEcCtD
Dextroamphetamine—Dermatitis—Clopidogrel—coronary artery disease	0.000133	0.000704	CcSEcCtD
Dextroamphetamine—Asthenia—Valsartan—coronary artery disease	0.000133	0.000703	CcSEcCtD
Dextroamphetamine—Hypertension—Timolol—coronary artery disease	0.000133	0.000703	CcSEcCtD
Dextroamphetamine—Constipation—Furosemide—coronary artery disease	0.000133	0.000703	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Niacin—coronary artery disease	0.000133	0.000702	CcSEcCtD
Dextroamphetamine—Asthenia—Olmesartan—coronary artery disease	0.000132	0.0007	CcSEcCtD
Dextroamphetamine—Headache—Clopidogrel—coronary artery disease	0.000132	0.0007	CcSEcCtD
Dextroamphetamine—Rash—Lovastatin—coronary artery disease	0.000132	0.0007	CcSEcCtD
Dextroamphetamine—Dermatitis—Lovastatin—coronary artery disease	0.000132	0.000699	CcSEcCtD
Dextroamphetamine—Dyspepsia—Losartan—coronary artery disease	0.000132	0.000698	CcSEcCtD
Dextroamphetamine—Headache—Lovastatin—coronary artery disease	0.000131	0.000695	CcSEcCtD
Dextroamphetamine—Dry mouth—Ramipril—coronary artery disease	0.000131	0.000694	CcSEcCtD
Dextroamphetamine—Chest pain—Timolol—coronary artery disease	0.000131	0.000693	CcSEcCtD
Dextroamphetamine—Vomiting—Ezetimibe—coronary artery disease	0.000131	0.000692	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Pravastatin—coronary artery disease	0.00013	0.000692	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Perindopril—coronary artery disease	0.00013	0.000691	CcSEcCtD
Dextroamphetamine—Anxiety—Timolol—coronary artery disease	0.00013	0.000691	CcSEcCtD
Dextroamphetamine—Angioedema—Lisinopril—coronary artery disease	0.00013	0.00069	CcSEcCtD
Dextroamphetamine—Decreased appetite—Losartan—coronary artery disease	0.00013	0.000689	CcSEcCtD
Dextroamphetamine—Abdominal pain—Captopril—coronary artery disease	0.00013	0.000688	CcSEcCtD
Dextroamphetamine—Body temperature increased—Captopril—coronary artery disease	0.00013	0.000688	CcSEcCtD
Dextroamphetamine—Dizziness—Simvastatin—coronary artery disease	0.00013	0.000687	CcSEcCtD
Dextroamphetamine—Rash—Ezetimibe—coronary artery disease	0.00013	0.000686	CcSEcCtD
Dextroamphetamine—Dermatitis—Ezetimibe—coronary artery disease	0.000129	0.000686	CcSEcCtD
Dextroamphetamine—Asthenia—Niacin—coronary artery disease	0.000129	0.000684	CcSEcCtD
Dextroamphetamine—Fatigue—Losartan—coronary artery disease	0.000129	0.000684	CcSEcCtD
Dextroamphetamine—Headache—Ezetimibe—coronary artery disease	0.000129	0.000682	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Ramipril—coronary artery disease	0.000128	0.00068	CcSEcCtD
Dextroamphetamine—Dry mouth—Timolol—coronary artery disease	0.000128	0.000678	CcSEcCtD
Dextroamphetamine—Constipation—Losartan—coronary artery disease	0.000128	0.000678	CcSEcCtD
Dextroamphetamine—Vomiting—Eplerenone—coronary artery disease	0.000128	0.000678	CcSEcCtD
Dextroamphetamine—Nausea—Fenofibrate—coronary artery disease	0.000127	0.000675	CcSEcCtD
Dextroamphetamine—Asthenia—Pravastatin—coronary artery disease	0.000127	0.000673	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Furosemide—coronary artery disease	0.000127	0.000672	CcSEcCtD
Dextroamphetamine—Rash—Eplerenone—coronary artery disease	0.000127	0.000672	CcSEcCtD
Dextroamphetamine—Urticaria—Perindopril—coronary artery disease	0.000127	0.000672	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Trandolapril—coronary artery disease	0.000127	0.000672	CcSEcCtD
Dextroamphetamine—Dermatitis—Eplerenone—coronary artery disease	0.000127	0.000671	CcSEcCtD
Dextroamphetamine—Diarrhoea—Valsartan—coronary artery disease	0.000127	0.000671	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Enalapril—coronary artery disease	0.000126	0.000669	CcSEcCtD
Dextroamphetamine—Body temperature increased—Perindopril—coronary artery disease	0.000126	0.000668	CcSEcCtD
Dextroamphetamine—Abdominal pain—Perindopril—coronary artery disease	0.000126	0.000668	CcSEcCtD
Dextroamphetamine—Palpitations—Lisinopril—coronary artery disease	0.000126	0.000668	CcSEcCtD
Dextroamphetamine—Diarrhoea—Olmesartan—coronary artery disease	0.000126	0.000668	CcSEcCtD
Dextroamphetamine—Headache—Eplerenone—coronary artery disease	0.000126	0.000668	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Timolol—coronary artery disease	0.000125	0.000665	CcSEcCtD
Dextroamphetamine—Nausea—Clopidogrel—coronary artery disease	0.000125	0.000664	CcSEcCtD
Dextroamphetamine—Tachycardia—Ramipril—coronary artery disease	0.000125	0.000664	CcSEcCtD
Dextroamphetamine—Infection—Timolol—coronary artery disease	0.000125	0.00066	CcSEcCtD
Dextroamphetamine—Vomiting—Simvastatin—coronary artery disease	0.000125	0.00066	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—ADRB2—coronary artery disease	0.000125	0.0284	CrCbGaD
Dextroamphetamine—Hypersensitivity—Telmisartan—coronary artery disease	0.000124	0.00066	CcSEcCtD
Dextroamphetamine—Nausea—Lovastatin—coronary artery disease	0.000124	0.000659	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Ramipril—coronary artery disease	0.000124	0.000657	CcSEcCtD
Dextroamphetamine—Rash—Simvastatin—coronary artery disease	0.000124	0.000655	CcSEcCtD
Dextroamphetamine—Dermatitis—Simvastatin—coronary artery disease	0.000123	0.000654	CcSEcCtD
Dextroamphetamine—Asthenia—Trandolapril—coronary artery disease	0.000123	0.000654	CcSEcCtD
Dextroamphetamine—Urticaria—Furosemide—coronary artery disease	0.000123	0.000653	CcSEcCtD
Dextroamphetamine—Diarrhoea—Niacin—coronary artery disease	0.000123	0.000652	CcSEcCtD
Dextroamphetamine—Asthenia—Enalapril—coronary artery disease	0.000123	0.000651	CcSEcCtD
Dextroamphetamine—Headache—Simvastatin—coronary artery disease	0.000123	0.00065	CcSEcCtD
Dextroamphetamine—Abdominal pain—Furosemide—coronary artery disease	0.000123	0.00065	CcSEcCtD
Dextroamphetamine—Body temperature increased—Furosemide—coronary artery disease	0.000123	0.00065	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Losartan—coronary artery disease	0.000122	0.000648	CcSEcCtD
Dextroamphetamine—Dizziness—Valsartan—coronary artery disease	0.000122	0.000648	CcSEcCtD
Dextroamphetamine—Anorexia—Ramipril—coronary artery disease	0.000122	0.000648	CcSEcCtD
Dextroamphetamine—Nausea—Ezetimibe—coronary artery disease	0.000122	0.000647	CcSEcCtD
Dextroamphetamine—Dizziness—Olmesartan—coronary artery disease	0.000122	0.000645	CcSEcCtD
Dextroamphetamine—Chest pain—Lisinopril—coronary artery disease	0.000121	0.000643	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Timolol—coronary artery disease	0.000121	0.000643	CcSEcCtD
Dextroamphetamine—Asthenia—Telmisartan—coronary artery disease	0.000121	0.000642	CcSEcCtD
Dextroamphetamine—Diarrhoea—Pravastatin—coronary artery disease	0.000121	0.000642	CcSEcCtD
Dextroamphetamine—Anxiety—Lisinopril—coronary artery disease	0.000121	0.000641	CcSEcCtD
Dextroamphetamine—Anorexia—Timolol—coronary artery disease	0.00012	0.000634	CcSEcCtD
Dextroamphetamine—Nausea—Eplerenone—coronary artery disease	0.000119	0.000633	CcSEcCtD
Dextroamphetamine—Dizziness—Niacin—coronary artery disease	0.000119	0.00063	CcSEcCtD
Dextroamphetamine—Urticaria—Losartan—coronary artery disease	0.000119	0.00063	CcSEcCtD
Dextroamphetamine—Dry mouth—Lisinopril—coronary artery disease	0.000119	0.000629	CcSEcCtD
Dextroamphetamine—Abdominal pain—Losartan—coronary artery disease	0.000118	0.000627	CcSEcCtD
Dextroamphetamine—Body temperature increased—Losartan—coronary artery disease	0.000118	0.000627	CcSEcCtD
Dextroamphetamine—Asthenia—Captopril—coronary artery disease	0.000118	0.000625	CcSEcCtD
Dextroamphetamine—Diarrhoea—Trandolapril—coronary artery disease	0.000118	0.000624	CcSEcCtD
Dextroamphetamine—Vomiting—Valsartan—coronary artery disease	0.000118	0.000623	CcSEcCtD
Dextroamphetamine—Diarrhoea—Enalapril—coronary artery disease	0.000117	0.000621	CcSEcCtD
Dextroamphetamine—Dizziness—Pravastatin—coronary artery disease	0.000117	0.000621	CcSEcCtD
Dextroamphetamine—Vomiting—Olmesartan—coronary artery disease	0.000117	0.00062	CcSEcCtD
Dextroamphetamine—Rash—Valsartan—coronary artery disease	0.000117	0.000618	CcSEcCtD
Dextroamphetamine—Dermatitis—Valsartan—coronary artery disease	0.000117	0.000618	CcSEcCtD
Dextroamphetamine—Nausea—Simvastatin—coronary artery disease	0.000116	0.000617	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000116	0.000617	CcSEcCtD
Dextroamphetamine—Rash—Olmesartan—coronary artery disease	0.000116	0.000615	CcSEcCtD
Dextroamphetamine—Insomnia—Ramipril—coronary artery disease	0.000116	0.000615	CcSEcCtD
Dextroamphetamine—Dermatitis—Olmesartan—coronary artery disease	0.000116	0.000615	CcSEcCtD
Dextroamphetamine—Headache—Valsartan—coronary artery disease	0.000116	0.000614	CcSEcCtD
Dextroamphetamine—Diarrhoea—Telmisartan—coronary artery disease	0.000116	0.000613	CcSEcCtD
Dextroamphetamine—Infection—Lisinopril—coronary artery disease	0.000116	0.000613	CcSEcCtD
Dextroamphetamine—Headache—Olmesartan—coronary artery disease	0.000115	0.000611	CcSEcCtD
Dextroamphetamine—Asthenia—Perindopril—coronary artery disease	0.000114	0.000607	CcSEcCtD
Dextroamphetamine—Dyspnoea—Ramipril—coronary artery disease	0.000114	0.000606	CcSEcCtD
Dextroamphetamine—Vomiting—Niacin—coronary artery disease	0.000114	0.000606	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Furosemide—coronary artery disease	0.000114	0.000606	CcSEcCtD
Dextroamphetamine—Somnolence—Ramipril—coronary artery disease	0.000114	0.000604	CcSEcCtD
Dextroamphetamine—Dizziness—Trandolapril—coronary artery disease	0.000114	0.000603	CcSEcCtD
Dextroamphetamine—Tachycardia—Lisinopril—coronary artery disease	0.000114	0.000602	CcSEcCtD
Dextroamphetamine—Insomnia—Timolol—coronary artery disease	0.000113	0.000601	CcSEcCtD
Dextroamphetamine—Rash—Niacin—coronary artery disease	0.000113	0.000601	CcSEcCtD
Dextroamphetamine—Dermatitis—Niacin—coronary artery disease	0.000113	0.000601	CcSEcCtD
Dextroamphetamine—Dizziness—Enalapril—coronary artery disease	0.000113	0.0006	CcSEcCtD
Dextroamphetamine—Dyspepsia—Ramipril—coronary artery disease	0.000113	0.000599	CcSEcCtD
Dextroamphetamine—Headache—Niacin—coronary artery disease	0.000113	0.000597	CcSEcCtD
Dextroamphetamine—Vomiting—Pravastatin—coronary artery disease	0.000113	0.000597	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000112	0.000596	CcSEcCtD
Dextroamphetamine—Diarrhoea—Captopril—coronary artery disease	0.000112	0.000596	CcSEcCtD
Dextroamphetamine—Dyspnoea—Timolol—coronary artery disease	0.000112	0.000593	CcSEcCtD
Dextroamphetamine—Dizziness—Telmisartan—coronary artery disease	0.000112	0.000592	CcSEcCtD
Dextroamphetamine—Rash—Pravastatin—coronary artery disease	0.000112	0.000592	CcSEcCtD
Dextroamphetamine—Dermatitis—Pravastatin—coronary artery disease	0.000112	0.000591	CcSEcCtD
Dextroamphetamine—Decreased appetite—Ramipril—coronary artery disease	0.000112	0.000591	CcSEcCtD
Dextroamphetamine—Somnolence—Timolol—coronary artery disease	0.000112	0.000591	CcSEcCtD
Dextroamphetamine—Asthenia—Furosemide—coronary artery disease	0.000111	0.00059	CcSEcCtD
Dextroamphetamine—Headache—Pravastatin—coronary artery disease	0.000111	0.000588	CcSEcCtD
Dextroamphetamine—Anorexia—Lisinopril—coronary artery disease	0.000111	0.000588	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000111	0.000587	CcSEcCtD
Dextroamphetamine—Fatigue—Ramipril—coronary artery disease	0.000111	0.000586	CcSEcCtD
Dextroamphetamine—Dyspepsia—Timolol—coronary artery disease	0.00011	0.000585	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Losartan—coronary artery disease	0.00011	0.000584	CcSEcCtD
Dextroamphetamine—Nausea—Valsartan—coronary artery disease	0.00011	0.000582	CcSEcCtD
Dextroamphetamine—Constipation—Ramipril—coronary artery disease	0.00011	0.000581	CcSEcCtD
Dextroamphetamine—Nausea—Olmesartan—coronary artery disease	0.000109	0.00058	CcSEcCtD
Dextroamphetamine—Vomiting—Trandolapril—coronary artery disease	0.000109	0.00058	CcSEcCtD
Dextroamphetamine—Diarrhoea—Perindopril—coronary artery disease	0.000109	0.000578	CcSEcCtD
Dextroamphetamine—Decreased appetite—Timolol—coronary artery disease	0.000109	0.000578	CcSEcCtD
Dextroamphetamine—Vomiting—Enalapril—coronary artery disease	0.000109	0.000577	CcSEcCtD
Dextroamphetamine—Dizziness—Captopril—coronary artery disease	0.000109	0.000576	CcSEcCtD
Dextroamphetamine—Rash—Trandolapril—coronary artery disease	0.000108	0.000575	CcSEcCtD
Dextroamphetamine—Dermatitis—Trandolapril—coronary artery disease	0.000108	0.000574	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Timolol—coronary artery disease	0.000108	0.000574	CcSEcCtD
Dextroamphetamine—Fatigue—Timolol—coronary artery disease	0.000108	0.000573	CcSEcCtD
Dextroamphetamine—Rash—Enalapril—coronary artery disease	0.000108	0.000572	CcSEcCtD
Dextroamphetamine—Dermatitis—Enalapril—coronary artery disease	0.000108	0.000572	CcSEcCtD
Dextroamphetamine—Headache—Trandolapril—coronary artery disease	0.000108	0.000571	CcSEcCtD
Dextroamphetamine—Vomiting—Telmisartan—coronary artery disease	0.000107	0.000569	CcSEcCtD
Dextroamphetamine—Asthenia—Losartan—coronary artery disease	0.000107	0.000569	CcSEcCtD
Dextroamphetamine—Headache—Enalapril—coronary artery disease	0.000107	0.000569	CcSEcCtD
Dextroamphetamine—Nausea—Niacin—coronary artery disease	0.000107	0.000566	CcSEcCtD
Dextroamphetamine—Rash—Telmisartan—coronary artery disease	0.000107	0.000565	CcSEcCtD
Dextroamphetamine—Dermatitis—Telmisartan—coronary artery disease	0.000106	0.000564	CcSEcCtD
Dextroamphetamine—Diarrhoea—Furosemide—coronary artery disease	0.000106	0.000562	CcSEcCtD
Dextroamphetamine—Headache—Telmisartan—coronary artery disease	0.000106	0.000561	CcSEcCtD
Dextroamphetamine—Dizziness—Perindopril—coronary artery disease	0.000105	0.000559	CcSEcCtD
Dextroamphetamine—Insomnia—Lisinopril—coronary artery disease	0.000105	0.000558	CcSEcCtD
Dextroamphetamine—Nausea—Pravastatin—coronary artery disease	0.000105	0.000558	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Ramipril—coronary artery disease	0.000105	0.000556	CcSEcCtD
Dextroamphetamine—Selegiline—CYP2C19—coronary artery disease	0.000105	0.0238	CrCbGaD
Dextroamphetamine—Vomiting—Captopril—coronary artery disease	0.000104	0.000554	CcSEcCtD
Dextroamphetamine—Dyspnoea—Lisinopril—coronary artery disease	0.000104	0.00055	CcSEcCtD
Dextroamphetamine—Rash—Captopril—coronary artery disease	0.000104	0.000549	CcSEcCtD
Dextroamphetamine—Dermatitis—Captopril—coronary artery disease	0.000103	0.000549	CcSEcCtD
Dextroamphetamine—Somnolence—Lisinopril—coronary artery disease	0.000103	0.000548	CcSEcCtD
Dextroamphetamine—Headache—Captopril—coronary artery disease	0.000103	0.000545	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Timolol—coronary artery disease	0.000103	0.000544	CcSEcCtD
Dextroamphetamine—Dizziness—Furosemide—coronary artery disease	0.000103	0.000543	CcSEcCtD
Dextroamphetamine—Dyspepsia—Lisinopril—coronary artery disease	0.000102	0.000543	CcSEcCtD
Dextroamphetamine—Diarrhoea—Losartan—coronary artery disease	0.000102	0.000543	CcSEcCtD
Dextroamphetamine—Nausea—Trandolapril—coronary artery disease	0.000102	0.000541	CcSEcCtD
Dextroamphetamine—Urticaria—Ramipril—coronary artery disease	0.000102	0.00054	CcSEcCtD
Dextroamphetamine—Nausea—Enalapril—coronary artery disease	0.000102	0.000539	CcSEcCtD
Dextroamphetamine—Vomiting—Perindopril—coronary artery disease	0.000101	0.000538	CcSEcCtD
Dextroamphetamine—Abdominal pain—Ramipril—coronary artery disease	0.000101	0.000538	CcSEcCtD
Dextroamphetamine—Body temperature increased—Ramipril—coronary artery disease	0.000101	0.000538	CcSEcCtD
Dextroamphetamine—Decreased appetite—Lisinopril—coronary artery disease	0.000101	0.000536	CcSEcCtD
Dextroamphetamine—Rash—Perindopril—coronary artery disease	0.000101	0.000533	CcSEcCtD
Dextroamphetamine—Dermatitis—Perindopril—coronary artery disease	0.0001	0.000533	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.0001	0.000532	CcSEcCtD
Dextroamphetamine—Nausea—Telmisartan—coronary artery disease	0.0001	0.000532	CcSEcCtD
Dextroamphetamine—Fatigue—Lisinopril—coronary artery disease	0.0001	0.000532	CcSEcCtD
Dextroamphetamine—Headache—Perindopril—coronary artery disease	9.99e-05	0.00053	CcSEcCtD
Dextroamphetamine—Urticaria—Timolol—coronary artery disease	9.96e-05	0.000528	CcSEcCtD
Dextroamphetamine—Constipation—Lisinopril—coronary artery disease	9.95e-05	0.000527	CcSEcCtD
Dextroamphetamine—Body temperature increased—Timolol—coronary artery disease	9.91e-05	0.000525	CcSEcCtD
Dextroamphetamine—Abdominal pain—Timolol—coronary artery disease	9.91e-05	0.000525	CcSEcCtD
Dextroamphetamine—Dizziness—Losartan—coronary artery disease	9.89e-05	0.000524	CcSEcCtD
Dextroamphetamine—Vomiting—Furosemide—coronary artery disease	9.86e-05	0.000523	CcSEcCtD
Dextroamphetamine—Rash—Furosemide—coronary artery disease	9.78e-05	0.000518	CcSEcCtD
Dextroamphetamine—Dermatitis—Furosemide—coronary artery disease	9.77e-05	0.000518	CcSEcCtD
Dextroamphetamine—Nausea—Captopril—coronary artery disease	9.76e-05	0.000517	CcSEcCtD
Dextroamphetamine—Headache—Furosemide—coronary artery disease	9.71e-05	0.000515	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Lisinopril—coronary artery disease	9.51e-05	0.000504	CcSEcCtD
Dextroamphetamine—Vomiting—Losartan—coronary artery disease	9.51e-05	0.000504	CcSEcCtD
Dextroamphetamine—Nausea—Perindopril—coronary artery disease	9.48e-05	0.000502	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Ramipril—coronary artery disease	9.45e-05	0.000501	CcSEcCtD
Dextroamphetamine—Rash—Losartan—coronary artery disease	9.43e-05	0.0005	CcSEcCtD
Dextroamphetamine—Dermatitis—Losartan—coronary artery disease	9.43e-05	0.0005	CcSEcCtD
Dextroamphetamine—Headache—Losartan—coronary artery disease	9.37e-05	0.000497	CcSEcCtD
Dextroamphetamine—Urticaria—Lisinopril—coronary artery disease	9.24e-05	0.00049	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Timolol—coronary artery disease	9.24e-05	0.00049	CcSEcCtD
Dextroamphetamine—Phenelzine—CYP2C19—coronary artery disease	9.22e-05	0.021	CrCbGaD
Dextroamphetamine—Nausea—Furosemide—coronary artery disease	9.21e-05	0.000488	CcSEcCtD
Dextroamphetamine—Asthenia—Ramipril—coronary artery disease	9.2e-05	0.000488	CcSEcCtD
Dextroamphetamine—Body temperature increased—Lisinopril—coronary artery disease	9.2e-05	0.000487	CcSEcCtD
Dextroamphetamine—Abdominal pain—Lisinopril—coronary artery disease	9.2e-05	0.000487	CcSEcCtD
Dextroamphetamine—Asthenia—Timolol—coronary artery disease	9e-05	0.000477	CcSEcCtD
Dextroamphetamine—Nausea—Losartan—coronary artery disease	8.89e-05	0.000471	CcSEcCtD
Dextroamphetamine—Diarrhoea—Ramipril—coronary artery disease	8.78e-05	0.000465	CcSEcCtD
Dextroamphetamine—Diarrhoea—Timolol—coronary artery disease	8.58e-05	0.000455	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Lisinopril—coronary artery disease	8.57e-05	0.000454	CcSEcCtD
Dextroamphetamine—Dizziness—Ramipril—coronary artery disease	8.48e-05	0.00045	CcSEcCtD
Dextroamphetamine—Asthenia—Lisinopril—coronary artery disease	8.35e-05	0.000442	CcSEcCtD
Dextroamphetamine—Dizziness—Timolol—coronary artery disease	8.29e-05	0.00044	CcSEcCtD
Dextroamphetamine—Vomiting—Ramipril—coronary artery disease	8.16e-05	0.000432	CcSEcCtD
Dextroamphetamine—Rash—Ramipril—coronary artery disease	8.09e-05	0.000429	CcSEcCtD
Dextroamphetamine—Dermatitis—Ramipril—coronary artery disease	8.08e-05	0.000428	CcSEcCtD
Dextroamphetamine—Headache—Ramipril—coronary artery disease	8.04e-05	0.000426	CcSEcCtD
Dextroamphetamine—Vomiting—Timolol—coronary artery disease	7.97e-05	0.000423	CcSEcCtD
Dextroamphetamine—Diarrhoea—Lisinopril—coronary artery disease	7.96e-05	0.000422	CcSEcCtD
Dextroamphetamine—Rash—Timolol—coronary artery disease	7.91e-05	0.000419	CcSEcCtD
Dextroamphetamine—Dermatitis—Timolol—coronary artery disease	7.9e-05	0.000419	CcSEcCtD
Dextroamphetamine—Headache—Timolol—coronary artery disease	7.86e-05	0.000416	CcSEcCtD
Dextroamphetamine—Dizziness—Lisinopril—coronary artery disease	7.69e-05	0.000408	CcSEcCtD
Dextroamphetamine—Nausea—Ramipril—coronary artery disease	7.62e-05	0.000404	CcSEcCtD
Dextroamphetamine—Nausea—Timolol—coronary artery disease	7.45e-05	0.000395	CcSEcCtD
Dextroamphetamine—Vomiting—Lisinopril—coronary artery disease	7.4e-05	0.000392	CcSEcCtD
Dextroamphetamine—Rash—Lisinopril—coronary artery disease	7.34e-05	0.000389	CcSEcCtD
Dextroamphetamine—Dermatitis—Lisinopril—coronary artery disease	7.33e-05	0.000388	CcSEcCtD
Dextroamphetamine—Headache—Lisinopril—coronary artery disease	7.29e-05	0.000386	CcSEcCtD
Dextroamphetamine—Nausea—Lisinopril—coronary artery disease	6.91e-05	0.000366	CcSEcCtD
Dextroamphetamine—Nateglinide—ALB—coronary artery disease	5.19e-05	0.0118	CrCbGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRB1—coronary artery disease	8.65e-06	8.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DUSP6—coronary artery disease	8.62e-06	8.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AGT—coronary artery disease	8.61e-06	8.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PPP2CA—coronary artery disease	8.58e-06	8.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL2—coronary artery disease	8.54e-06	8.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL3—coronary artery disease	8.54e-06	8.06e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CA—coronary artery disease	8.49e-06	8.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLAT—coronary artery disease	8.47e-06	7.99e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	8.45e-06	7.98e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOA2—coronary artery disease	8.45e-06	7.98e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GPX2—coronary artery disease	8.45e-06	7.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SDC1—coronary artery disease	8.44e-06	7.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—F2R—coronary artery disease	8.44e-06	7.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PRKCD—coronary artery disease	8.42e-06	7.95e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SULT1A1—coronary artery disease	8.35e-06	7.88e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GPX4—coronary artery disease	8.35e-06	7.88e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HK1—coronary artery disease	8.35e-06	7.88e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCG5—coronary artery disease	8.35e-06	7.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGB—coronary artery disease	8.26e-06	7.8e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HADHA—coronary artery disease	8.25e-06	7.79e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR2A—coronary artery disease	8.24e-06	7.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—C3—coronary artery disease	8.23e-06	7.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EDNRB—coronary artery disease	8.18e-06	7.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL12—coronary artery disease	8.17e-06	7.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BDKRB2—coronary artery disease	8.17e-06	7.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—POMC—coronary artery disease	8.16e-06	7.7e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTA1—coronary artery disease	8.16e-06	7.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—F2—coronary artery disease	8.13e-06	7.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6ST—coronary artery disease	8.1e-06	7.65e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LPA—coronary artery disease	8.06e-06	7.61e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—THBS1—coronary artery disease	8.05e-06	7.6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JUNB—coronary artery disease	8.02e-06	7.57e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLCB1—coronary artery disease	7.99e-06	7.54e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PSMB5—coronary artery disease	7.97e-06	7.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PSMA6—coronary artery disease	7.97e-06	7.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—F2—coronary artery disease	7.96e-06	7.51e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR7—coronary artery disease	7.83e-06	7.39e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AGT—coronary artery disease	7.82e-06	7.38e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PLCB3—coronary artery disease	7.81e-06	7.37e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOA5—coronary artery disease	7.73e-06	7.3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EDNRA—coronary artery disease	7.72e-06	7.29e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CYBA—coronary artery disease	7.69e-06	7.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRB1—coronary artery disease	7.69e-06	7.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DUSP6—coronary artery disease	7.65e-06	7.22e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—P4HB—coronary artery disease	7.58e-06	7.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLAT—coronary artery disease	7.52e-06	7.1e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—coronary artery disease	7.52e-06	7.1e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ITGAV—coronary artery disease	7.46e-06	7.04e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	7.44e-06	7.02e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KNG1—coronary artery disease	7.43e-06	7.02e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—POMC—coronary artery disease	7.41e-06	6.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CREB1—coronary artery disease	7.41e-06	6.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AGTR1—coronary artery disease	7.39e-06	6.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL12—coronary artery disease	7.26e-06	6.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BDKRB2—coronary artery disease	7.26e-06	6.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL2—coronary artery disease	7.25e-06	6.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—POMC—coronary artery disease	7.25e-06	6.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6R—coronary artery disease	7.23e-06	6.82e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—F2—coronary artery disease	7.23e-06	6.82e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL10—coronary artery disease	7.22e-06	6.82e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLG—coronary artery disease	7.2e-06	6.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6ST—coronary artery disease	7.2e-06	6.79e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JUNB—coronary artery disease	7.12e-06	6.72e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLCB1—coronary artery disease	7.1e-06	6.7e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—VCAN—coronary artery disease	7.02e-06	6.62e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRB2—coronary artery disease	7.01e-06	6.62e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALDOA—coronary artery disease	6.96e-06	6.57e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR7—coronary artery disease	6.95e-06	6.56e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—AKT1—coronary artery disease	6.94e-06	6.55e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCE—coronary artery disease	6.92e-06	6.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—JAK2—coronary artery disease	6.92e-06	6.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SOCS1—coronary artery disease	6.9e-06	6.52e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—S100B—coronary artery disease	6.89e-06	6.5e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SOCS3—coronary artery disease	6.82e-06	6.44e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DCN—coronary artery disease	6.76e-06	6.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFBR2—coronary artery disease	6.74e-06	6.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KITLG—coronary artery disease	6.74e-06	6.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ITGAV—coronary artery disease	6.62e-06	6.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KNG1—coronary artery disease	6.6e-06	6.23e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT5A—coronary artery disease	6.59e-06	6.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP3—coronary artery disease	6.59e-06	6.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—POMC—coronary artery disease	6.58e-06	6.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CREB1—coronary artery disease	6.58e-06	6.21e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALDH2—coronary artery disease	6.57e-06	6.2e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AGTR1—coronary artery disease	6.56e-06	6.19e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL2—coronary artery disease	6.44e-06	6.08e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6R—coronary artery disease	6.42e-06	6.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL10—coronary artery disease	6.42e-06	6.05e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	6.41e-06	6.05e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LIPC—coronary artery disease	6.41e-06	6.05e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HBA1—coronary artery disease	6.41e-06	6.05e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	6.41e-06	6.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLG—coronary artery disease	6.4e-06	6.04e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOC3—coronary artery disease	6.37e-06	6.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOB—coronary artery disease	6.37e-06	6.01e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LDLR—coronary artery disease	6.33e-06	5.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL8—coronary artery disease	6.31e-06	5.96e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—JAK2—coronary artery disease	6.28e-06	5.93e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EDN1—coronary artery disease	6.27e-06	5.91e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	6.25e-06	5.9e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTT1—coronary artery disease	6.25e-06	5.9e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRB2—coronary artery disease	6.23e-06	5.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL5—coronary artery disease	6.22e-06	5.87e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CETP—coronary artery disease	6.18e-06	5.83e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GCLC—coronary artery disease	6.18e-06	5.83e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCE—coronary artery disease	6.15e-06	5.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—JAK2—coronary artery disease	6.14e-06	5.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SOCS1—coronary artery disease	6.13e-06	5.79e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CSF2—coronary artery disease	6.12e-06	5.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGF1—coronary artery disease	6.12e-06	5.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—S100B—coronary artery disease	6.12e-06	5.77e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SDC1—coronary artery disease	6.11e-06	5.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LPL—coronary artery disease	6.08e-06	5.74e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SOCS3—coronary artery disease	6.06e-06	5.72e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MEF2C—coronary artery disease	6.02e-06	5.69e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RPS6KB1—coronary artery disease	6.02e-06	5.69e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFBR2—coronary artery disease	5.99e-06	5.65e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KITLG—coronary artery disease	5.99e-06	5.65e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ITGB3—coronary artery disease	5.87e-06	5.54e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT5A—coronary artery disease	5.85e-06	5.52e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP3—coronary artery disease	5.85e-06	5.52e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PSMB5—coronary artery disease	5.77e-06	5.45e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PSMA6—coronary artery disease	5.77e-06	5.45e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL8—coronary artery disease	5.73e-06	5.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PPP2CA—coronary artery disease	5.7e-06	5.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOB—coronary artery disease	5.66e-06	5.34e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CTGF—coronary artery disease	5.64e-06	5.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL8—coronary artery disease	5.61e-06	5.29e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCD—coronary artery disease	5.6e-06	5.29e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HMGCR—coronary artery disease	5.59e-06	5.28e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GOT2—coronary artery disease	5.59e-06	5.28e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—JAK2—coronary artery disease	5.58e-06	5.26e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EDN1—coronary artery disease	5.57e-06	5.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL5—coronary artery disease	5.52e-06	5.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2A—coronary artery disease	5.48e-06	5.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—C3—coronary artery disease	5.47e-06	5.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CSF2—coronary artery disease	5.44e-06	5.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGF1—coronary artery disease	5.44e-06	5.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LPL—coronary artery disease	5.4e-06	5.1e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MEF2C—coronary artery disease	5.35e-06	5.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RPS6KB1—coronary artery disease	5.35e-06	5.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HIF1A—coronary artery disease	5.22e-06	4.93e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	5.22e-06	4.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AGT—coronary artery disease	5.2e-06	4.91e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PLCB1—coronary artery disease	5.14e-06	4.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LEP—coronary artery disease	5.1e-06	4.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOE—coronary artery disease	5.1e-06	4.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	5.09e-06	4.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	5.07e-06	4.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOA1—coronary artery disease	5.04e-06	4.75e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KDR—coronary artery disease	4.99e-06	4.71e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCA1—coronary artery disease	4.98e-06	4.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	4.98e-06	4.69e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	4.96e-06	4.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	4.87e-06	4.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	4.86e-06	4.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—C3—coronary artery disease	4.86e-06	4.59e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GGT1—coronary artery disease	4.83e-06	4.55e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GOT1—coronary artery disease	4.83e-06	4.55e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—F2—coronary artery disease	4.81e-06	4.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FN1—coronary artery disease	4.81e-06	4.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	4.79e-06	4.52e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	4.75e-06	4.48e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	4.64e-06	4.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AGT—coronary artery disease	4.62e-06	4.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KIT—coronary artery disease	4.6e-06	4.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LEP—coronary artery disease	4.53e-06	4.27e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOE—coronary artery disease	4.53e-06	4.27e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	4.47e-06	4.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KDR—coronary artery disease	4.43e-06	4.18e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	4.41e-06	4.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	4.41e-06	4.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—POMC—coronary artery disease	4.38e-06	4.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	4.38e-06	4.13e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTP1—coronary artery disease	4.33e-06	4.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	4.32e-06	4.08e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	4.29e-06	4.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	4.28e-06	4.04e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HMOX1—coronary artery disease	4.27e-06	4.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	4.27e-06	4.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—F2—coronary artery disease	4.27e-06	4.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FN1—coronary artery disease	4.27e-06	4.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	4.25e-06	4.01e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAT—coronary artery disease	4.22e-06	3.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	4.22e-06	3.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	4.21e-06	3.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	4.19e-06	3.95e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOB—coronary artery disease	4.09e-06	3.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KIT—coronary artery disease	4.08e-06	3.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	4e-06	3.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	4e-06	3.77e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.98e-06	3.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	3.92e-06	3.7e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LPL—coronary artery disease	3.91e-06	3.69e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—POMC—coronary artery disease	3.89e-06	3.67e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	3.89e-06	3.67e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	3.87e-06	3.65e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	3.82e-06	3.6e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GPX1—coronary artery disease	3.81e-06	3.6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	3.8e-06	3.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	3.79e-06	3.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	3.74e-06	3.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	3.72e-06	3.51e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CD36—coronary artery disease	3.71e-06	3.51e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	3.71e-06	3.5e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	3.67e-06	3.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	3.64e-06	3.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	3.56e-06	3.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	3.55e-06	3.35e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—coronary artery disease	3.52e-06	3.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	3.44e-06	3.24e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	3.39e-06	3.2e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	3.39e-06	3.2e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AGT—coronary artery disease	3.34e-06	3.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	3.3e-06	3.11e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOE—coronary artery disease	3.28e-06	3.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	3.27e-06	3.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	3.24e-06	3.06e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOA1—coronary artery disease	3.24e-06	3.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.23e-06	3.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	3.22e-06	3.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	3.15e-06	2.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	3.06e-06	2.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	3.01e-06	2.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	2.97e-06	2.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	2.91e-06	2.74e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	2.88e-06	2.72e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	2.86e-06	2.7e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARG—coronary artery disease	2.85e-06	2.69e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—POMC—coronary artery disease	2.82e-06	2.66e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	2.8e-06	2.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	2.75e-06	2.6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	2.72e-06	2.57e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	2.64e-06	2.49e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALB—coronary artery disease	2.57e-06	2.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	2.52e-06	2.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	2.48e-06	2.34e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NOS3—coronary artery disease	2.46e-06	2.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	2.44e-06	2.31e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—coronary artery disease	2.25e-06	2.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	2.24e-06	2.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	2.2e-06	2.08e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	2.15e-06	2.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	1.91e-06	1.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	1.9e-06	1.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	1.75e-06	1.66e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	1.69e-06	1.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	1.56e-06	1.47e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.38e-06	1.3e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.13e-06	1.07e-05	CbGpPWpGaD
